Michael L. Cheng
Impact in
- Virology top 5%
- HIV Research and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 17
-
- Lung Cancer Treatments and Mutations 12
- Renal cell carcinoma treatment 3
- Co-authors
- Lawrence Fong (3 shared papers)Mark M. Awad (8 shared papers)Geoffrey R. Oxnard (7 shared papers)Biagio Ricciuti (6 shared papers)Mizuki Nishino (6 shared papers)Eirini Pectasides (1 shared paper)Atish D. Choudhury (1 shared paper)Heather A. Parsons (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)JCO Precision Oncology (5 papers)Clinical Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)Urologic Oncology Seminars and Original Investigations (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Michael L. Cheng
40 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Virology 117
- Cancer Research 338
- Oncology 508
- Pulmonary and Respiratory Medicine 367
- Immunology 218
Countries citing papers authored by Michael L. Cheng
This map shows the geographic impact of Michael L. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Cheng more than expected).
Fields of papers citing papers by Michael L. Cheng
This network shows the impact of papers produced by Michael L. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Cheng. The network helps show where Michael L. Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael L. Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 124 | |
| 2 | 2021 | 108 | |
| 3 | 2005 | 103 | |
| 4 | 2020 | 102 | |
| 5 | 2021 | 96 | |
| 6 | 2014 | 66 | |
| 7 | 2015 | 48 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 30 | |
| 10 | 2013 | 30 | |
| 11 | 2020 | 28 | |
| 12 | 2012 | 26 | |
| 13 | 2005 | 25 | |
| 14 | 2020 | 21 | |
| 15 | 2021 | 20 | |
| 16 | 2019 | 20 | |
| 17 | Productivity prediction from well logs in variable grain size reservoirs, Cretaceous Qishn Clastics, Republic of Yemen | 1998 | 16 |
| 18 | 2021 | 15 | |
| 19 | 2014 | 14 | |
| 20 | 2012 | 14 |
About Michael L. Cheng
Michael L. Cheng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Immunology, having authored 43 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Hydrocarbon exploration and reservoir analysis (4 papers), Immunotherapy and Immune Responses (4 papers), Lung Cancer Research Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Virology (117 citations), Cancer Research (338 citations), Oncology (508 citations), Pulmonary and Respiratory Medicine (367 citations) and Immunology (218 citations). Michael L. Cheng has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Lawrence Fong, Mark M. Awad, Geoffrey R. Oxnard, Biagio Ricciuti, Mizuki Nishino, Eirini Pectasides, Atish D. Choudhury, Heather A. Parsons, Glenn J. Hanna and Lynette M. Sholl. Their work appears in journals such as Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.